Table 1.
Patient characteristics.
| Benign (n = 238) | BOT I+II (n = 144) | EOC I+II (n = 108) | |
|---|---|---|---|
| Age (year) | 32.0 (27.0-40.0) | 32.0 (27.0-41.0) | 48.0 (41.0-58.75)∗^ |
| Premenopausal | 218 | 122 | 61 |
| Postmenopausal | 20 | 22 | 47 |
| FIGO stages | |||
| I | — | 140 | 76 |
| II | — | 4 | 32 |
| Histopathology | |||
| Serous | — | 91 | 43 |
| Mucinous | — | 40 | 10 |
| Endometrioid | — | 9 | 23 |
| Clear cell | — | 4 | 32 |
Note: data of age are presented as the median (interquartile range). Abbreviations: n = number; FIGO = International Federation of Gynecology and Obstetrics; BOT I+II = borderline ovarian tumors in FIGO stages I and II; EOC I+II = epithelial ovarian cancer in FIGO stages I and II.